Actively Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Led by Peking University First Hospital · Updated on 2026-05-14
200
Participants Needed
1
Research Sites
148 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
CONDITIONS
Official Title
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided written and voluntary informed consent
- Male or female aged 18 years or older at time of consent
- Able to understand the study and willing to comply with all protocol requirements
- Have histologically confirmed or suspected tumors such as Clear Cell Renal Cell Cancer, Urothelial Carcinoma, Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Head and Neck Cancer, Hepatocellular Carcinoma, Cholangiocarcinoma, Non Small Cell Lung Cancer, Small Cell Lung Cancer, Breast Cancer, Pancreatic Cancer, Endometrial Cancer, or Von Hippel Lindau Disease
You will not qualify if you...
- Have any serious non-malignant disease (psychiatric, infectious, autoimmune, or metabolic) that may interfere with study objectives or participant safety
- Have a mental impairment compromising informed consent or study compliance
- Are pregnant or breastfeeding female
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
Research Team
K
Keting Tong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here